Episode Details

Please support this podcast by checking out our sponsors:
- KrispCall: Agentic Cloud Telephony - https://try.krispcall.com/tad
- Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily
- Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad


Support The Automated Daily directly:
Buy me a coffee: https://buymeacoffee.com/theautomateddaily

Today's topics:

KRAS drug shifts pancreatic cancer - An experimental KRAS-targeting drug, daraxonrasib, showed a notable survival gain in metastatic pancreatic cancer and is now FDA fast-tracked—important progress in a long “undruggable” target.

CAR-T style approach against HIV - Early trial results suggest engineered T cells, similar to CAR-T, may keep HIV suppressed without daily antiretroviral therapy for extended periods, raising hopes for a functional cure.

Twice-yearly HIV shot made local - Unitaid plans to select a South African lab to produce a generic lenacapavir, a twice-yearly injectable for HIV prevention and treatment, strengthening regional supply and access.

EU considers social media age rules - EU Commission President Ursula von der Leyen signaled potential minimum-age rules for social media and new limits on addictive design features under a coming Digital Fairness Act.

AI and cyber risks to nukes - A new analysis warns AI-accelerated discovery of software vulnerabilities could heighten cyber threats to nuclear command-and-control systems, challenging key assumptions behind deterrence stability.

TSMC sees trillion-dollar chip boom - TSMC now forecasts the semiconductor market could top $1.5 trillion by 2030, driven by AI and high-performance computing, alongside major fab and advanced-packaging expansion plans.

AI speeds new antibiotic discovery - University of Pennsylvania researchers unveiled ApexGO, an AI-guided method that iteratively improves antimicrobial peptides, a promising route as antibiotic resistance intensifies.

Homo erectus proteins rewrite links - Protein evidence extracted from Homo erectus teeth in China suggests intriguing genetic links involving Denisovans and some modern populations, while showcasing minimally destructive paleoproteomics methods.

The pill at 66 and politics - On the 66th anniversary of the first oral contraceptive approval, new coverage revisits how the pill reshaped education, work, and family planning—and why contraception access remains politically contested.

Episode Transcript

KRAS drug shifts pancreatic cancer
First, health and medicine—and the headline here is pancreatic cancer.
A late-stage study of an experimental drug called daraxonrasib is giving the field something it hasn’t had in a long time: real momentum. The drug targets KRAS, a key driver behind most pancreatic tumors—and many lung and colon cancers too.
For decades, KRAS was the poster child for “we can’t hit that with a drug.” Now, with a newer strategy that essentially helps the drug latch on and shut KRAS down, the results are turning heads. In patients with metastatic disease who had already failed chemotherapy, the company reported a median survival of more than 13 months on daraxonrasib, compared with under seven months on standa